peer
review
http
bmjopenbmjcomsiteaboutguidelinesxhtml
bmj
open
peer
review
http
bmjopenbmjcomsiteaboutguidelinesxhtml
bmj
open
word
count
word
abstract
introduct
sever
trauma
repres
lead
caus
mortal
worldwid
death
occur
within
first
hour
trauma
occur
later
mainli
due
healthcareassoci
infect
includ
ventilatorassoci
pneumonia
vap
prevent
underinfl
tracheal
cuff
recommend
reduc
microaspir
play
major
role
pathogenesi
vap
automat
devic
facilit
regul
tracheal
cuff
pressur
implement
potenti
reduc
vap
object
work
determin
whether
continu
regul
tracheal
cuff
pressur
use
pneumat
devic
reduc
incid
vap
compar
intermitt
control
sever
trauma
patient
multicentr
randomis
control
openlabel
trial
includ
patient
suffer
sever
trauma
admit
within
first
hour
requir
invas
mechan
ventil
longer
hour
tracheal
cuff
pressur
monitor
either
everi
hour
control
group
continu
use
pneumat
devic
intervent
group
primari
endpoint
proport
patient
develop
vap
intens
care
unit
icu
secondari
endpoint
includ
proport
patient
develop
vap
icu
earli
day
late
day
vap
time
first
vap
diagnosi
number
ventilatorfre
day
antibioticfre
day
length
stay
icu
proport
patient
ventil
associ
event
die
icu
stay
ethic
dissemin
protocol
approv
ethic
committe
poitier
univers
hospit
carri
accord
principl
declar
helsinki
good
clinic
practic
guidelin
result
studi
peer
review
http
bmjopenbmjcomsiteaboutguidelinesxhtml
bmj
open
pneumonia
mechan
ventil
sever
trauma
patient
agat
studi
protocol
studi
conduct
multicentr
randomis
control
openlabel
trial
adequ
power
determin
whether
continu
regul
tracheal
cuff
pressur
use
pneumat
devic
reduc
incid
ventil
associ
pneumonia
first
larg
studi
topic
potenti
chang
intern
recommend
ventil
associ
pneumonia
prevent
studi
benefit
includ
reduc
durat
mechan
ventil
stay
icu
improv
patient
prognosi
reduct
antibiot
use
limit
due
lack
mask
relat
natur
intervent
limit
mask
endpoint
assess
sever
trauma
repres
lead
caus
mortal
worldwid
third
highest
caus
death
franc
behind
cardiovascular
diseas
cancer
death
follow
trauma
occur
per
inhabit
per
year
franc
repres
close
death
death
occur
within
first
hour
trauma
directli
relat
trauma
death
occur
later
mainli
due
healthcareassoci
infect
hai
patient
present
sever
trauma
develop
least
one
hai
stay
neurolog
disord
recours
mechan
ventil
earli
posttraumat
immun
suppress
may
explain
elev
incid
hai
particularli
ventilatorassoci
pneumonia
vap
mainli
occur
first
week
follow
trauma
ventilatorassoci
pneumonia
repres
predomin
hai
sever
trauma
patient
mean
incid
may
even
exceed
seri
follow
cathet
infect
bacteraemia
hai
account
heighten
morbid
mortal
longer
stay
icu
increas
treatment
cost
franc
addit
cost
estim
million
per
year
infect
also
requir
high
use
antibiot
vap
alon
make
half
antibiot
treatment
prescrib
icu
given
select
pressur
induc
antibiot
therapi
favour
appear
bacteri
resist
ventilatorassoci
pneumonia
pathophysiolog
presenc
foreign
materi
tracheal
tube
stomach
tube
facilit
colonis
upper
airway
digest
tract
endogen
exogen
microorgan
maintain
suffici
level
pressur
tracheal
tube
cuff
critic
import
pressur
low
patient
risk
inhal
accumul
subglott
secret
oropharynx
known
play
major
role
vap
incid
f
r
p
e
e
r
r
e
v
e
w
n
l
altern
pressur
high
risk
ischemia
tracheal
mucosa
remov
tracheal
oedema
later
tracheal
stenosi
therefor
regular
monitor
tracheal
cuff
pressur
recommend
optim
monitor
frequenc
yet
clearli
determin
underinfl
andor
overinfl
tracheal
cuff
often
occur
ventil
patient
intermitt
manual
control
tracheal
cuff
pressur
use
manomet
wellknown
sourc
morbid
mortal
recent
publish
data
favour
use
automat
devic
abl
continu
regul
tracheal
cuff
pressur
object
studi
determin
whether
continu
regul
tracheal
cuff
pressur
use
mechan
pneumat
regul
devic
leve
pari
superior
agat
trial
multicentr
randomis
control
openlabel
clinic
trial
two
parallel
group
primari
endpoint
proport
patient
develop
vap
icu
day
randomis
carri
secur
webbas
randomis
system
stratifi
centr
sever
patient
unconsci
time
inclus
glasgow
coma
scale
lower
higher
equal
patient
consid
candid
inclus
studi
meet
inclus
criteria
none
exclus
criteria
tabl
patient
suffer
sever
trauma
admit
within
first
hour
requir
invas
mechan
ventil
expect
last
longer
hour
includ
studi
case
patient
inclus
take
place
soon
possibl
icu
admiss
hour
follow
trauma
andor
hour
follow
oral
intub
trachea
pregnant
lactat
women
includ
studi
materi
use
present
specif
risk
teratogen
patient
includ
studi
randomis
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
benefit
daili
monitor
throughout
hospit
stay
icu
follow
criteria
appli
patient
control
throughout
durat
studi
implement
ident
sedat
wean
protocol
centr
implement
lung
protect
ventil
strategi
maintain
tidal
volum
mlkg
ideal
bodi
weight
posit
end
expiratori
pressur
peep
cmh
respiratori
rate
set
achiev
normocapnia
option
moder
hypocapnia
accord
protocol
observ
unit
extub
consid
soon
patient
glasgow
coma
score
patient
cough
spontan
secondari
bronchial
aspir
level
pressur
support
cm
h
spontan
ventil
tpiec
f
lower
toler
patient
least
minut
systemat
chang
respir
circuit
preferenti
use
heat
humid
exchang
filter
chang
soil
systemat
applic
bed
inclin
least
monitor
everi
hour
hand
wash
hydroalcohol
friction
prior
treatment
follow
isol
measur
mouth
care
everi
hour
accord
protocol
observ
unit
tracheal
aspir
carri
use
steril
equip
perform
requir
preferenti
oral
insert
feed
tube
start
enter
feed
soon
possibl
systemat
applic
glucos
monitor
protocol
patient
blood
sugar
level
measur
everi
hour
object
maintain
glucos
level
mmoll
prophylact
antibiot
treatment
limit
hour
fractur
oper
within
first
hour
cur
antibiot
therapi
reserv
infect
bacteri
origin
antibiot
therapi
reevalu
hour
prevent
ulcer
diseas
antih
proton
pump
inhibitor
accord
protocol
observ
centr
primari
endpoint
tabl
number
ventilatorfre
day
number
antibioticfre
day
length
stay
icu
proport
patient
die
icu
stay
proport
patient
requir
corticosteroid
bronchodil
within
hour
tracheal
extub
attempt
detect
vap
sign
perform
daili
basi
patient
mechan
ventil
accord
definit
establish
at
tabl
thorac
xray
aim
detect
vap
carri
within
hour
whenev
least
two
follow
clinic
sign
vap
observ
whenev
patient
meet
clinic
radiolog
criteria
day
vap
suspect
modifi
clinic
pulmonari
infect
score
cpi
calcul
present
tabl
bacteri
analysi
respiratori
tract
carri
especi
calcul
score
type
sampl
bronchoalveolar
lavag
blind
distal
sampl
tracheal
aspir
left
discret
attend
physician
depend
procedur
unit
patient
suspect
develop
vap
two
assessor
mask
group
assign
review
casereport
form
classifi
case
accord
accept
definit
patient
monitor
randomis
discharg
icu
without
exceed
day
follow
inclus
evalu
assess
criteria
carri
depend
durat
patient
stay
icu
evalu
carri
upon
discharg
icu
patient
icu
stay
day
evalu
carri
day
upon
discharg
icu
patient
icu
stay
day
evalu
carri
day
day
patient
icu
stay
day
patient
leav
icu
consid
exit
studi
readmiss
icu
even
within
day
follow
trauma
taken
account
patient
exit
studi
wish
without
provid
justif
qualiti
care
alter
outcom
taken
account
final
analysi
number
particip
n
group
base
estim
vap
incid
patient
control
group
reduc
vap
incid
halv
intervent
group
studi
power
pvalu
bilater
situat
given
recruit
potenti
centr
approach
particip
studi
togeth
constraint
associ
protocol
expect
inclus
durat
set
month
patient
admit
icu
french
univers
hospit
screen
enrol
within
hour
trauma
patient
enrol
decid
attend
physician
computergener
number
list
provid
statistician
involv
either
screen
patient
assess
outcom
randomis
carri
use
secur
webbas
randomis
system
stratif
centr
sever
unconsci
time
inclus
glasgow
coma
scale
account
f
r
p
e
e
r
r
e
v
e
w
n
l
differ
patient
treatment
centr
heighten
vap
risk
patient
glasgow
coma
scale
lower
patient
randomli
assign
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
mask
particip
icu
staff
feasibl
due
natur
devic
place
close
patient
face
howev
microbiologist
test
pulmonari
blood
sampl
outcom
assessor
nm
om
statistician
mask
group
assign
independ
clinic
research
assist
avail
particip
hospit
help
run
studi
data
collect
studi
document
deidentifi
store
year
per
protocol
nonclin
trial
notif
ctn
intervent
studi
data
electron
store
doubl
passwordprotect
comput
hard
copi
data
clinic
research
file
store
lock
secur
offic
personnel
involv
data
analysi
mask
princip
investig
statistician
access
final
data
set
analys
perform
follow
intentiontotreat
principl
randomis
patient
except
withdrew
consent
statist
analys
take
account
f
r
p
e
e
r
r
e
v
e
w
n
l
categor
variabl
report
number
percentag
continu
variabl
summaris
use
mean
standard
deviat
sd
median
interquartil
rang
iqr
normal
nonnorm
distribut
data
along
respect
confid
interv
analys
primari
endpoint
secondari
endpoint
relat
vap
incid
use
logist
regress
model
adjust
stratif
factor
cumul
event
curv
time
first
vap
diagnosi
estim
use
kaplanmei
procedur
number
ventilatorfre
day
vfd
number
day
patient
success
wean
mechan
ventil
endpoint
day
day
defin
follow
vfd
patient
die
within
day
requir
mechan
ventil
day
vfd
x
patient
success
wean
mechan
ventil
within
day
x
number
day
mechan
ventil
number
antibioticfre
day
afd
number
day
live
patient
receiv
antibiot
day
prophylact
cur
antibiot
therapi
relat
trauma
consid
vfd
afd
assess
manner
compar
group
use
regress
model
allow
adjust
stratif
factor
categor
secondari
endpoint
compar
group
use
logist
regress
model
statist
analys
conduct
use
sa
softwar
miss
data
describ
number
correspond
percentag
group
presenc
imbal
proport
miss
data
treatment
group
evalu
use
logist
regress
model
assess
robust
result
case
miss
data
sensit
analys
perform
imput
miss
data
worst
valu
failur
death
etc
multipl
imput
clinic
research
associ
ensur
patient
inclus
data
collect
registri
rapport
line
protocol
studi
conduct
accord
good
clinic
practic
guidelin
furthermor
verifi
follow
variabl
patient
initi
date
birth
sex
sign
consent
form
elig
criteria
date
randomis
treatment
assign
advers
event
studi
endpoint
clinic
trial
carri
line
principl
declar
helsinki
prior
consent
subject
possibl
therefor
consent
subject
legal
accept
repres
request
consent
form
specif
design
subject
legal
accept
repres
provid
document
approv
favour
opinion
institut
review
board
order
protect
right
safeti
wellb
subject
ensur
complianc
applic
regulatori
requir
nonobject
particip
studi
patient
rel
solicit
accord
requir
ethic
committe
peopl
direct
access
data
take
necessari
precaut
maintain
confidenti
data
collect
studi
render
anonym
initi
inclus
number
regist
result
studi
releas
particip
physician
refer
physician
medic
commun
later
year
complet
trial
present
scientif
confer
public
peerreview
journal
work
support
grant
french
ministri
social
affair
health
number
funder
role
studi
concept
data
analysi
best
knowledg
first
largescal
studi
evalu
use
continu
pneumat
regul
tracheal
cuff
pressur
popul
sever
trauma
patient
also
benefit
recommend
vap
prevent
measur
individu
level
benefit
expect
includ
reduc
durat
mechan
ventil
stay
icu
well
improv
patient
prognosi
collect
level
order
keep
manag
practic
standardis
possibl
decid
limit
number
investig
centr
univers
hospit
centr
chu
recognis
field
trauma
care
treat
sever
trauma
patient
per
year
centr
belong
three
network
share
common
object
promot
present
studi
addit
risk
incur
studi
particip
term
usual
therapi
receiv
hospit
stay
patient
care
usual
attend
physician
supplementari
examin
impos
protocol
patient
unabl
hear
given
inform
inform
regard
studi
deliv
close
rel
friend
accord
direct
french
nation
commiss
data
protect
liberti
patient
afford
possibl
object
use
data
gather
name
anoth
limit
studi
mask
feasibl
due
natur
intervent
howev
endpoint
assess
two
assessor
mask
group
assign
order
minimis
bia
trial
current
progress
inclus
process
start
juli
time
manuscript
submiss
patient
includ
first
patient
includ
day
registr
studi
clinicaltrialsgov
estim
last
patient
recruit
januari
conclus
trial
first
multicentr
randomis
control
openlabel
studi
adequ
power
test
hypothesi
continu
pneumat
regul
tracheal
cuff
pressur
prevent
ventilatorassoci
pneumonia
mechan
ventil
sever
trauma
patient
thank
physician
nurs
staff
clinic
research
associ
particip
center
particip
studi
om
conceiv
studi
coordin
design
draft
manuscript
french
ministri
social
affair
health
grant
number
data
provid
full
paper
audibert
alexandr
bergi
patient
age
least
year
suffer
sever
trauma
defin
injuri
sever
score
iss
tracheal
intub
via
oral
rout
less
requir
mechan
ventil
expect
length
particip
social
secur
scheme
benefit
scheme
mean
third
parti
patient
follow
exclud
studi
patient
like
die
h
follow
admiss
trachea
intub
via
nasal
rout
patient
intub
tracheal
tube
subglott
secret
drainag
trachea
intub
h
trauma
two
clinic
sign
among
follow
fever
hypothermia
purul
endotrach
aspir
hyperleucocytosi
leucopenia
one
radiolog
sign
new
radiograph
condens
modif
previous
exist
radiograph
condens
posit
bacteri
analysi
respiratori
tract
cultur
least
cfuml
brush
fibroscopi
blind
protect
distal
sampl
cfuml
bronchoalveolar
lavag
cfuml
tracheal
aspir
dissemin
present
scientif
confer
public
peerreview
journal
studi
conduct
multicentr
randomis
control
openlabel
trial
adequ
power
determin
whether
continu
regul
tracheal
cuff
pressur
use
pneumat
devic
reduc
incid
ventil
associ
pneumonia
first
larg
studi
topic
potenti
chang
intern
recommend
ventil
associ
pneumonia
prevent
studi
benefit
includ
reduc
durat
mechan
ventil
stay
icu
improv
patient
prognosi
reduct
antibiot
use
limit
due
lack
mask
relat
natur
intervent
limit
mask
endpoint
assess
ventilatorassoci
pneumonia
repres
predomin
hai
sever
trauma
patient
mean
incid
may
even
exceed
seri
follow
cathet
infect
bacteraemia
hai
account
heighten
morbid
mortal
longer
stay
icu
increas
treatment
cost
franc
addit
cost
estim
million
per
year
infect
also
requir
high
use
antibiot
vap
alon
make
half
antibiot
treatment
prescrib
icu
given
select
pressur
induc
antibiot
therapi
favour
appear
bacteri
resist
presenc
foreign
materi
tracheal
tube
stomach
tube
facilit
colonis
upper
airway
digest
tract
endogen
exogen
microorgan
maintain
suffici
level
pressur
tracheal
tube
cuff
critic
import
pressur
low
patient
risk
inhal
accumul
subglott
secret
oropharynx
known
play
major
role
vap
incid
object
studi
determin
whether
continu
regul
tracheal
cuff
pressur
use
mechan
pneumat
regul
devic
leve
pari
superior
agat
trial
multicentr
randomis
control
openlabel
clinic
trial
two
parallel
group
primari
endpoint
proport
patient
develop
vap
icu
day
randomis
carri
secur
webbas
randomis
system
stratifi
centr
sever
patient
unconsci
time
inclus
glasgow
coma
scale
lower
higher
equal
patient
consid
candid
inclus
studi
meet
inclus
criteria
none
exclus
criteria
lactat
women
includ
studi
materi
use
present
specif
risk
teratogen
patient
includ
studi
randomis
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
benefit
daili
monitor
throughout
hospit
stay
icu
follow
criteria
appli
patient
control
throughout
durat
studi
implement
ident
sedat
wean
protocol
centr
systemat
chang
respir
circuit
preferenti
use
heat
humid
exchang
filter
chang
soil
systemat
applic
bed
inclin
least
monitor
everi
hour
hand
wash
hydroalcohol
friction
prior
treatment
follow
isol
measur
mouth
care
everi
hour
accord
protocol
observ
unit
tracheal
aspir
carri
use
steril
equip
perform
requir
preferenti
oral
insert
feed
tube
start
enter
feed
soon
possibl
systemat
applic
glucos
monitor
protocol
patient
blood
sugar
level
measur
everi
hour
object
maintain
glucos
level
mmoll
prophylact
antibiot
treatment
limit
hour
fractur
oper
within
first
hour
concentr
site
infect
recours
serum
assay
use
whenev
possibl
avoid
underdos
common
caus
failur
well
avoid
overdos
lead
iatrogen
patholog
narrowspectrum
antibiot
antibiot
therapi
reevalu
hour
prevent
ulcer
diseas
antih
proton
pump
inhibitor
accord
protocol
observ
centr
primari
endpoint
number
ventilatorfre
day
number
antibioticfre
day
length
stay
icu
proport
patient
die
icu
stay
proport
patient
requir
corticosteroid
bronchodil
within
hour
tracheal
extub
attempt
detect
vap
sign
perform
daili
basi
patient
mechan
ventil
accord
definit
establish
at
tabl
thorac
xray
aim
detect
vap
carri
within
hour
whenev
least
two
follow
clinic
sign
vap
observ
whenev
patient
meet
clinic
radiolog
criteria
day
vap
suspect
modifi
clinic
pulmonari
infect
score
cpi
calcul
present
tabl
bacteri
analysi
respiratori
tract
carri
especi
calcul
score
type
sampl
bronchoalveolar
lavag
blind
distal
sampl
tracheal
aspir
left
discret
attend
physician
depend
procedur
unit
patient
suspect
develop
vap
two
assessor
mask
group
assign
review
casereport
form
classifi
case
accord
accept
definit
patient
monitor
randomis
discharg
icu
without
exceed
day
follow
inclus
evalu
assess
criteria
carri
depend
durat
patient
stay
icu
evalu
carri
upon
discharg
icu
patient
icu
stay
day
evalu
carri
day
upon
discharg
icu
patient
icu
stay
day
evalu
carri
day
day
patient
icu
stay
day
patient
leav
icu
consid
exit
studi
readmiss
icu
even
within
day
follow
trauma
taken
account
patient
exit
studi
wish
without
provid
justif
qualiti
care
alter
outcom
taken
account
final
analysi
number
particip
n
group
base
estim
vap
incid
patient
control
group
reduc
vap
incid
halv
intervent
group
studi
power
pvalu
bilater
situat
vap
incid
control
group
chosen
basi
unpublish
analysi
databas
french
research
network
devot
studi
trauma
patient
given
recruit
potenti
centr
approach
particip
studi
togeth
constraint
associ
protocol
expect
inclus
durat
set
month
patient
admit
icu
french
univers
hospit
screen
enrol
within
hour
trauma
patient
enrol
decid
attend
physician
computergener
number
list
provid
statistician
involv
either
screen
patient
assess
outcom
randomis
carri
use
secur
webbas
randomis
system
stratif
centr
sever
unconsci
time
inclus
glasgow
coma
scale
account
differ
patient
treatment
centr
heighten
vap
risk
patient
glasgow
coma
scale
lower
patient
randomli
assign
one
two
treatment
group
base
method
use
monitor
tracheal
cuff
pressur
mask
particip
icu
staff
feasibl
due
natur
devic
place
close
patient
face
howev
microbiologist
test
pulmonari
blood
sampl
outcom
assessor
nm
om
statistician
mask
group
assign
independ
clinic
research
assist
avail
particip
hospit
help
run
studi
data
collect
studi
document
deidentifi
store
year
per
protocol
nonclin
trial
notif
ctn
intervent
studi
data
electron
store
doubl
passwordprotect
comput
hard
copi
data
clinic
research
file
store
lock
secur
offic
personnel
involv
data
analysi
mask
princip
investig
statistician
access
final
data
set
analys
perform
follow
intentiontotreat
principl
randomis
patient
except
withdrew
consent
statist
analys
take
account
categor
variabl
report
number
percentag
continu
variabl
summaris
use
mean
standard
deviat
sd
median
interquartil
rang
iqr
normal
nonnorm
distribut
data
along
respect
confid
interv
analys
primari
endpoint
secondari
endpoint
relat
vap
incid
use
logist
regress
model
adjust
stratif
factor
covari
significantli
imbalanc
group
cumul
event
curv
time
first
vap
diagnosi
estim
use
kaplanmei
procedur
number
ventilatorfre
day
vfd
number
day
patient
success
wean
mechan
ventil
endpoint
day
day
defin
follow
vfd
patient
die
within
day
requir
mechan
ventil
day
vfd
x
patient
success
wean
mechan
ventil
within
day
x
number
day
mechan
ventil
number
antibioticfre
day
afd
number
day
live
patient
receiv
antibiot
day
prophylact
cur
antibiot
therapi
relat
trauma
consid
vfd
afd
assess
manner
compar
group
use
regress
model
allow
adjust
stratif
factor
f
r
p
e
e
r
r
e
v
e
w
n
l
categor
secondari
endpoint
compar
group
use
logist
regress
model
statist
analys
conduct
use
sa
softwar
miss
data
describ
number
correspond
percentag
group
presenc
imbal
proport
miss
data
treatment
group
evalu
use
logist
regress
model
assess
robust
result
case
miss
data
sensit
analys
perform
imput
miss
data
worst
valu
failur
death
etc
multipl
imput
clinic
research
associ
ensur
patient
inclus
data
collect
registri
rapport
line
protocol
studi
conduct
accord
good
clinic
practic
guidelin
furthermor
verifi
follow
variabl
patient
initi
date
birth
sex
sign
consent
form
elig
criteria
date
randomis
treatment
assign
advers
event
studi
endpoint
clinic
trial
carri
line
principl
declar
helsinki
prior
consent
subject
possibl
therefor
consent
subject
legal
accept
repres
request
consent
form
specif
design
subject
legal
accept
repres
provid
document
approv
favour
opinion
institut
review
board
order
protect
right
safeti
wellb
subject
ensur
complianc
applic
regulatori
requir
nonobject
particip
studi
patient
rel
solicit
accord
requir
ethic
committe
peopl
direct
access
data
take
necessari
precaut
maintain
confidenti
data
collect
studi
render
anonym
initi
inclus
number
regist
result
studi
releas
particip
physician
refer
physician
medic
commun
later
year
complet
trial
present
scientif
confer
public
peerreview
journal
present
studi
addit
risk
incur
studi
particip
term
usual
therapi
receiv
hospit
stay
patient
care
usual
attend
physician
supplementari
examin
impos
protocol
patient
unabl
hear
given
inform
inform
regard
studi
deliv
close
rel
friend
accord
direct
french
nation
commiss
data
protect
liberti
patient
afford
possibl
object
use
data
gather
name
incid
vap
primari
endpoint
trial
howev
vap
diagnosi
may
difficult
perform
icu
mouth
care
stress
ulcer
prophylaxi
base
local
written
protocol
may
act
potenti
confound
variabl
howev
control
stratif
random
centr
level
adjust
statist
analys
case
differ
group
final
mask
feasibl
due
natur
intervent
howev
endpoint
assess
two
assessor
mask
group
assign
order
minimis
bia
trial
current
progress
inclus
process
start
juli
time
manuscript
submiss
patient
includ
first
patient
includ
day
registr
studi
clinicaltrialsgov
estim
last
patient
recruit
januari
thank
physician
nurs
staff
clinic
research
associ
particip
center
particip
studi
om
conceiv
studi
coordin
design
draft
manuscript
french
ministri
social
affair
health
grant
number
data
provid
full
paper
audibert
belaid
bouhemad
patient
age
least
year
suffer
sever
trauma
defin
injuri
sever
score
iss
tracheal
intub
via
oral
rout
less
requir
mechan
ventil
expect
length
particip
social
secur
scheme
benefit
scheme
mean
third
parti
patient
follow
exclud
studi
patient
like
die
h
follow
admiss
trachea
intub
via
nasal
rout
patient
intub
tracheal
tube
subglott
secret
drainag
trachea
intub
h
trauma
two
clinic
sign
among
follow
fever
hypothermia
purul
endotrach
aspir
hyperleucocytosi
leucopenia
one
radiolog
sign
new
radiograph
condens
modif
previous
exist
radiograph
condens
posit
bacteri
analysi
respiratori
tract
cultur
least
cfuml
brush
fibroscopi
blind
protect
distal
sampl
cfuml
bronchoalveolar
lavag
cfuml
tracheal
aspir
person
inform
potenti
enrol
particip
collect
share
maintain
order
protect
confidenti
trial
